Cargando…
Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck Cancer
IMPORTANCE: Oral mucositis (OM) is a common and debilitating adverse effect observed in patients with head and neck cancer (HNC) receiving radiation therapy (RT). Previous studies examining associations between OM and clinical outcomes were performed in the era of 3-dimensional conformal RT planning...
Autores principales: | Iovoli, Austin J., Turecki, Lauren, Qiu, Michelle L., Khan, Michael, Smith, Kelsey, Yu, Han, Ma, Sung Jun, Farrugia, Mark K., Singh, Anurag K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568356/ https://www.ncbi.nlm.nih.gov/pubmed/37819659 http://dx.doi.org/10.1001/jamanetworkopen.2023.37265 |
Ejemplares similares
-
Prophylactic High-Dose Gabapentin Reduces Opiate Use during Radiation Therapy for Head and Neck Squamous Cell Carcinoma
por: Qiu, Michelle L., et al.
Publicado: (2023) -
Trends in Postoperative Intensity-Modulated Radiation Therapy Use and Its Association With Survival Among Patients With Incompletely Resected Non–Small Cell Lung Cancer
por: Yu, Brian, et al.
Publicado: (2022) -
Narrative review of the management of oral mucositis during chemoradiation for head and neck cancer
por: Judge, Lauren F., et al.
Publicado: (2021) -
Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy
por: Iovoli, Austin J., et al.
Publicado: (2020) -
Association of Gabapentin Use With Pain Control and Feeding Tube Placement Among Patients With Head and Neck Cancer Receiving Chemoradiotherapy
por: Ma, Sung Jun, et al.
Publicado: (2022)